{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:34:07Z","timestamp":1793759647152,"version":"4.6.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Multidrug-resistant pathogens causing nosocomial and community acquired infections delineate a significant threat to public health. It had urged to identify new antimicrobials and thus, generated interest in studying macrocyclic metal complex, which has been studied in the past for their antimicrobial activity. Hence, in the present study, we have evaluated the antimicrobial activity of the hexadentated macrocyclic complex of copper (II) (Cu Complex) derived from thiosemicarbazide against Gram-positive and Gram-negative bacteria. We observed increased susceptibility against standard isolates of <jats:italic>Staphylococcus aureus<\/jats:italic> with a minimum inhibitory concentration (MIC) range of 6.25 to 12.5\u2009\u03bcg\/mL. Similar activity was also observed towards methicillin resistant and sensitive clinical isolates of <jats:italic>S. aureus<\/jats:italic> from human (n\u2009=\u200920) and animal (n\u2009=\u200920) infections. The compound has rapid bactericidal activity, and we did not observe any resistant mutant of <jats:italic>S. aureus<\/jats:italic>. The compound also exhibited antibiofilm activity and was able to disrupt pre-formed biofilms. Cu complex showed increased susceptibility towards intracellular <jats:italic>S. aureus<\/jats:italic> and was able to reduce more than 95% of the bacterial load at 10\u2009\u03bcg\/mL. Overall, our results suggest that Cu complex with its potent anti-microbial and anti-biofilm activity can be used to treat MRSA infections and evaluated further clinically.<\/jats:p>","DOI":"10.1038\/s41598-018-26483-5","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T10:11:56Z","timestamp":1526551916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Antimicrobial and anti-biofilm activity of hexadentated macrocyclic complex of copper (II) derived from thiosemicarbazide against Staphylococcus aureus"],"prefix":"10.1038","volume":"8","author":[{"given":"Umarani","family":"Brahma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paresh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasundhra","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,23]]},"reference":[{"key":"26483_CR1","doi-asserted-by":"publisher","first-page":"e0144094","DOI":"10.1371\/journal.pone.0144094","volume":"10","author":"C Ghosh","year":"2015","unstructured":"Ghosh, C. et al. Aryl-Alkyl Lysines: agents that kill planktonic cells, Persister cells, Biofilms of MRSA and protect mice from skin infections. PLoS. One. 10, e0144094 (2015).","journal-title":"PLoS. One."},{"key":"26483_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","volume":"109","author":"F Prestinaci","year":"2015","unstructured":"Prestinaci, F., Pezzotti, P. & Pantosti, A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog. Glob. Health. 109, 309\u2013318 (2015).","journal-title":"Pathog. Glob. Health."},{"key":"26483_CR3","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1128\/AAC.02008-12","volume":"57","author":"VJ Savage","year":"2013","unstructured":"Savage, V. J., Chopra, I. & O\u2019Neill, A. J. Staphylococus aureus Biofilms promote horizontal transfer of antibiotic resistance. Antimicrob. Agents. Chemother. 57, 1968\u20131970 (2013).","journal-title":"Antimicrob. Agents. Chemother."},{"key":"26483_CR4","unstructured":"Centers for Disease Control and Prevention, Office of Infectious Disease Antibiotic resistance threats in the United States, Apr, 2013. Available at: http:\/\/www.cdc.gov\/drugresistance\/threat-report-2013 (2013)."},{"key":"26483_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1473-3099(01)00091-3","volume":"1","author":"K Hiramatsu","year":"2001","unstructured":"Hiramatsu, K. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet. Infect. Dis. 1, 147\u201355 (2001).","journal-title":"Lancet. Infect. Dis."},{"key":"26483_CR6","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.1128\/AAC.00663-10","volume":"54","author":"JF Locke","year":"2010","unstructured":"Locke, J. F. et al. Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutations. Antimicrob. Agents. Chemother. 54, 5337\u20135343 (2010).","journal-title":"Antimicrob. Agents. Chemother."},{"key":"26483_CR7","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2217\/fmb.14.64","volume":"9","author":"SJ McConoughey","year":"2014","unstructured":"McConoughey, S. J. et al. Biofilms in periprosthetic orthopedic infections. Future. Microbiol. 9, 987\u20131007 (2014).","journal-title":"Future. Microbiol."},{"key":"26483_CR8","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1016\/j.biomaterials.2012.05.031","volume":"33","author":"CR Arciola","year":"2012","unstructured":"Arciola, C. R., Campoccia, D., Speziale, P., Montanaro, L. & Costerton, J. W. Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. Biomaterials. 33, 5967\u20135982 (2012).","journal-title":"Biomaterials."},{"key":"26483_CR9","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1574-695X.2010.00714.x","volume":"59","author":"M Burm\u00f8lle","year":"2010","unstructured":"Burm\u00f8lle, M. et al. Biofilms in chronic infections a matter of opportunity\u2013monospecies biofilms in multispecies infections. FEMS. Immunol. Med. Microbiol. 59, 324\u2013336 (2010).","journal-title":"FEMS. Immunol. Med. Microbiol."},{"key":"26483_CR10","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s10096-015-2323-z","volume":"34","author":"I Olsen","year":"2015","unstructured":"Olsen, I. Biofilm-specific antibiotic tolerance and resistance. Eur. J. Clin. Microbiol. 34, 877\u2013886 (2015).","journal-title":"Eur. J. Clin. Microbiol."},{"key":"26483_CR11","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1001\/jamainternmed.2013.9763","volume":"173","author":"E Zimlichman","year":"2013","unstructured":"Zimlichman, E., Henderson, D. & Tamir, O. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA. Intern. Med. 173, 2039\u20132046 (2013).","journal-title":"JAMA. Intern. Med."},{"key":"26483_CR12","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.tibtech.2016.05.016","volume":"34","author":"MT Buhmann","year":"2016","unstructured":"Buhmann, M. T., Stiefel, P., Maniura-Weber, K. & Ren, Q. In Vitro Biofilm Models for Device-Related Infections. Trends. Biotechnol. 34, 945\u2013946 (2016).","journal-title":"Trends. Biotechnol."},{"key":"26483_CR13","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2014.06.046","volume":"158","author":"G Koch","year":"2014","unstructured":"Koch, G. et al. Evolution of resistance to last-\u2018resort antibiotic in Staphylococcus aureus via bacterial competition. Cell. 158, 1060\u20131071 (2014).","journal-title":"Cell."},{"key":"26483_CR14","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/nbt1267","volume":"24","author":"REW Hancock","year":"2006","unstructured":"Hancock, R. E. W. & Sahl, H. G. Antimicrobial and host defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24, 1551\u20131557 (2006).","journal-title":"Nat. Biotechnol."},{"key":"26483_CR15","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/cmdc.201500299","volume":"10","author":"C Ghosh","year":"2015","unstructured":"Ghosh, C. & Haldar, J. Membrane active small molecules: Designs inspired from antimicrobial peptides. ChemMedChem. 10, 1606\u201324 (2015).","journal-title":"ChemMedChem."},{"key":"26483_CR16","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1021\/jm701600a","volume":"51","author":"BE Haug","year":"2008","unstructured":"Haug, B. E., Stensen, W., Kalaaji, M., Rekdal, O. & Svenden, J. S. Synthetic antimicrobial peptidomimetic (LTX 109): stereochemical impact on membrane disruption. J. Med. Chem. 51, 4306\u20134314 (2008).","journal-title":"J. Med. Chem."},{"key":"26483_CR17","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1021\/jm500270w","volume":"57","author":"V Yarlagadda","year":"2014","unstructured":"Yarlagadda, V., Konai, M. M., Manjunath, G. B. & Haldar, J. Membrane active vancomycin analogues: a strategy to combat bacterial resistance. J. Med. Chem. 57, 4558\u20134568 (2014).","journal-title":"J. Med. Chem."},{"key":"26483_CR18","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1128\/AEM.01599-10","volume":"77","author":"C EspiritoSanto","year":"2011","unstructured":"EspiritoSanto, C. et al. Bacterial killing by dry metallic copper surfaces. Appl. Environ. Microbiol. 77, 794\u2013802 (2011).","journal-title":"Appl. Environ. Microbiol."},{"key":"26483_CR19","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1128\/AEM.02766-10","volume":"77","author":"G Grass","year":"2011","unstructured":"Grass, G., Rensing, C. & Solioz, M. Metallic copper as an antimicrobial surface. Appl. Environ. Microbiol. 77, 1541\u20131547 (2011).","journal-title":"Appl. Environ. Microbiol."},{"key":"26483_CR20","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.chembiol.2014.06.009","volume":"21","author":"RA Festa","year":"2014","unstructured":"Festa, R. A., Helsel, M. E., Franz, K. J. & Thiele, D. J. Exploiting innate immune cell activation of a copper dependent antimicrobial agent during infection. Chem. Biol. 21, 977\u2013987 (2014).","journal-title":"Chem. Biol."},{"key":"26483_CR21","doi-asserted-by":"publisher","first-page":"6444","DOI":"10.1128\/AAC.01289-15","volume":"59","author":"KY Djoko","year":"2015","unstructured":"Djoko, K. Y. et al. Copper (II)- BIs (Thiosemicarbazonato) complexes as antibacterial agents: insights into their mode of action and potential as therapeutics. Antimicrob. Agents. Chemother. 59, 6444\u20136453 (2015).","journal-title":"Antimicrob. Agents. Chemother."},{"key":"26483_CR22","first-page":"708","volume":"5","author":"R Kothari","year":"2016","unstructured":"Kothari, R. et al. Design, synthesis, characterization and pharmalogical evaluation of copper mediated macrocyclic complexes. International. Jou. Biol. Pharma. Allied. Sci. 5, 708\u2013724 (2016).","journal-title":"International. Jou. Biol. Pharma. Allied. Sci."},{"key":"26483_CR23","doi-asserted-by":"publisher","first-page":"33949","DOI":"10.1074\/jbc.M109.070201","volume":"284","author":"C White","year":"2009","unstructured":"White, C., Lee, J., Kambe, T., Fritsche, K. & Petris, M. J. A role for the ATP7A copper-transporting ATPase in macrophage bactericidal activity. J. Biol. Chem. 284, 33949\u201333956 (2009).","journal-title":"J. Biol. Chem."},{"key":"26483_CR24","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3389\/fmicb.2017.01446","volume":"8","author":"S Mahato","year":"2017","unstructured":"Mahato, S. et al. Identification of variable traits among the methicillin resistant and sensitive coagulase negative staphylococci in milk samples from mastitic cows in India. Front. Microbiol. 8, 1446 (2017).","journal-title":"Front. Microbiol."},{"key":"26483_CR25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jprot.2016.09.014","volume":"150","author":"W Ma","year":"2017","unstructured":"Ma, W. et al. Antibacterial mechanism of daptomycin antibiotic against Staphylococcus aureus based on a quantitative bacterial proteome analysis. J. Proteomics. 150, 242\u2013251 (2017).","journal-title":"J. Proteomics."},{"key":"26483_CR26","doi-asserted-by":"publisher","first-page":"e0155139","DOI":"10.1371\/journal.pone.0155139","volume":"11","author":"E Gerits","year":"2016","unstructured":"Gerits, E., Blommaert, E. & Lippell, A. Elucidation of the Mode of Action of a New Antibacterial Compound Active against Staphylococcus aureus and Pseudomonas aeruginosa. PLoS. One. 11, e0155139 (2016).","journal-title":"PLoS. One."},{"key":"26483_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nature14098","volume":"517","author":"LL Ling","year":"2015","unstructured":"Ling, L. L. et al. A new antibiotic kills pathogens without detectable resistance. Nature. 517, 455\u2013459 (2015).","journal-title":"Nature."},{"key":"26483_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2015.17","volume":"4","author":"H Liu","year":"2015","unstructured":"Liu, H. et al. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains. Emerg. Microbes. Infect. 4, e17 (2015).","journal-title":"Emerg. Microbes. Infect."},{"key":"26483_CR29","doi-asserted-by":"publisher","first-page":"6046","DOI":"10.1128\/AAC.00991-15","volume":"59","author":"T Oja","year":"2015","unstructured":"Oja, T. et al. Effective Antibiofilm Polyketides against Staphylococcus aureus from the Pyranonaphthoquinone Biosynthetic Pathways of Streptomyces Species. Antimicrob. Agents. Chemother. 59, 6046\u20136052 (2015).","journal-title":"Antimicrob. Agents. Chemother."},{"key":"26483_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1472-765X.2007.02298.x","volume":"46","author":"K Tote","year":"2008","unstructured":"Tote, K., Berghe, V., Maes, L. & Cos, P. A new colorimetric microtitre model for the detection of Staphylococcus aureus biofilms. Lett. Appl. Microbiol. 46, 249\u2013254 (2008).","journal-title":"Lett. Appl. Microbiol."},{"key":"26483_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/ja.2016.101","volume":"70","author":"N Miyoshi","year":"2017","unstructured":"Miyoshi, N., Isogai, E., Hiramatsu, K. & Sasak, T. Activity of tick antimicrobial peptide from Ixodes persulcatus (persulcatusin) against cell membranes of drug-resistant Staphylococcus aureus. J. Antibiot (Tokyo). 70, 142\u2013146 (2017).","journal-title":"J. Antibiot (Tokyo)."},{"key":"26483_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1136\/pmj.78.921.385","volume":"78","author":"AS Hadadin","year":"2002","unstructured":"Hadadin, A. S., Fappiano, S. A. & Lipsett, P. A. Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. Postgrad. Med. J. 78, 223\u2013233 (2002).","journal-title":"Postgrad. Med. J."},{"key":"26483_CR33","doi-asserted-by":"publisher","first-page":"S231","DOI":"10.1086\/598189","volume":"48","author":"CK Naber","year":"2009","unstructured":"Naber, C. K. Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies. Clin. Infect. Dis. 48, S231\u2013237 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"26483_CR34","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1177\/000313481207801019","volume":"78","author":"J Manunga Jr.","year":"2012","unstructured":"Manunga, J. Jr., Olak, J., Rivera, C. & Martin, M. Prevalence of methicillin resistant Staphylococcus aureus in elective surgical patients at a public teaching hospital: an analysis of 1039 pateints. Am. Surg. 78, 1096\u20131099 (2012).","journal-title":"Am. Surg."},{"key":"26483_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0966-842X(00)01913-2","volume":"9","author":"TF Mah","year":"2001","unstructured":"Mah, T. F. & O\u2019Toole, G. A. Mechanisms of biofilm resistance to antimicrobial agents. Trends. Microbiol. 9, 34\u201339 (2001).","journal-title":"Trends. Microbiol."},{"key":"26483_CR36","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1128\/AAC.45.4.999-1007.2001","volume":"45","author":"K Lewis","year":"2001","unstructured":"Lewis, K. Riddle of biofilm resistance. Antimicrob. Agents. Chemother. 45, 999\u20131007 (2001).","journal-title":"Antimicrob. Agents. Chemother."},{"key":"26483_CR37","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro2200","volume":"7","author":"HF Chambers","year":"2009","unstructured":"Chambers, H. F. & DeLeo, F. R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7, 629\u2013641 (2009).","journal-title":"Nat. Rev. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26483-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26483-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26483-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T05:33:21Z","timestamp":1671600801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26483-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,23]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["26483"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-26483-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,23]]},"assertion":[{"value":"16 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8050"}}